Technical Analysis for AKAOQ - Achaogen Inc

Grade Last Price % Change Price Change
grade F 0.01 11.11% 0.0010
AKAOQ closed up 11.11 percent on Friday, January 24, 2020, on 2.27 times normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong Down Down Flat
Historical AKAOQ trend table...

Date Alert Name Type % Chg
Boomer Sell Setup Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish 11.11%
Spinning Top Other 11.11%
Wide Bands Range Expansion 11.11%
Lower Bollinger Band Touch Weakness 11.11%
Crossed Above 20 DMA Bullish -9.09%
Pocket Pivot Bullish Swing Setup -9.09%
Older signals for AKAOQ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Achaogen, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial agents for multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin for the treatment of serious bacterial infections due to MDR enterobacteriaceae comprising carbapenem-resistant enterobacteriaceae. It is also involved in the development of antibacterial candidate C-Scape, an orally-administered combination of clavulanate and ceftibuten, which targets serious bacterial infections due to expanded spectrum beta-lactamases producing enterobacteriaceae. The company has license and collaboration agreements with Thermo Fisher Scientific, Inc. to develop and commercialize an assay to support plazomicin; Crystal Biosciences, Inc. to discover monoclonal antibodies against multiple targets; Ionis Pharmaceuticals, Inc. for certain patents relating to aminoglycoside antibacterial compounds and related know-how to develop and commercialize certain novel aminoglycoside antibacterial compounds; and Hovione Limited manufacture the active pharmaceutical ingredient for plazomicin. The company was incorporated in 2002 and is based in South San Francisco, California. On April 15, 2019, Achaogen, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Medicine Biopharmaceutical Drugs U.S. Bankruptcy Court Infectious Diseases Antibodies U.S. Bankruptcy Court For The District Of Delaware Antibiotic Gram Negative Infections Multiple Drug Resistance Carbapenem

Is AKAOQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1.88
52 Week Low 0.006
Average Volume 163,735
200-Day Moving Average 0.0407
50-Day Moving Average 0.0116
20-Day Moving Average 0.0103
10-Day Moving Average 0.0100
Average True Range 0.0031
ADX 51.17
+DI 6.5116
-DI 13.7209
Chandelier Exit (Long, 3 ATRs ) 0.0037
Chandelier Exit (Short, 3 ATRs ) 0.0153
Upper Bollinger Band 0.0122
Lower Bollinger Band 0.0084
Percent B (%b) 0.42
BandWidth 36.8932
MACD Line -0.0004
MACD Signal Line -0.0005
MACD Histogram 0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0130
Resistance 3 (R3) 0.0127 0.0113 0.0125
Resistance 2 (R2) 0.0113 0.0106 0.0115 0.0123
Resistance 1 (R1) 0.0107 0.0101 0.0110 0.0110 0.0122
Pivot Point 0.0093 0.0093 0.0095 0.0095 0.0093
Support 1 (S1) 0.0087 0.0086 0.0090 0.0090 0.0078
Support 2 (S2) 0.0073 0.0081 0.0075 0.0077
Support 3 (S3) 0.0067 0.0073 0.0075
Support 4 (S4) 0.0070